Synergistic effects of pentoxifylline and dapsone in leucocytoclastic vasculitis

The Lancet

Volumn 343, Issue 8895, 1994, Pages 491-

  Nurnberg W ^a   Grabbe, J ^a   Czarnetzki, B M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DAPSONE; PENTOXIFYLLINE;

ADULT; CASE REPORT; DRUG POTENTIATION; FEMALE; HUMAN; LETTER; LEUKOCYTOCLASTIC VASCULITIS; PRIORITY JOURNAL;

EID: 0028036346     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)92746-4     Document Type: Letter

References (8)

1. Chronic leukocytoclastic vasculitis associated with polycythemia vera effective control with pentoxifylline
2. Pentoxifylline therapy in dermatology
3. Urticarial vasculitis
4. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones
5. Dapsone suppresses integrin-mediated neutrophil adherence function
6. Inhibition of neutophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses
7. In vitro modulation of normal and diseased human neutrophil function by pentoxifylline
8. Differential effect of oxpentifylline on tumour necrosis factor and interleukin-6 production